Pressure BioSciences (PINK:PBIO)(OTCQB:PBIO)
Thursday announced it has entered into distribution agreements with
three companies with combined coverage in six new countries.
The
company noted that the latest distribution deal brings the total number
of countries carrying its pressure cycling technology (PCT) preparation
instrument and consumable products to 11.
PCT is an enabling
technology platform with multiple applications in the life sciences
sample preparation market. Pressure noted that PCT uses rapid and
repeating cycles of hydrostatic pressure at controlled temperatures to
extract cell components in the preparation of a biological sample, such
as DNA and proteins from humans, animals and plants, for further study.
During
the first half of 2012, Pressure added four US partners and four
international distributors to help the company “aggressively market and
sell” its PCT instruments and consumables. Initial orders have already
been received from several of the new partners/distributors, the company
said.
“We believe that the number of such orders will continue
to increase, that products and programs planned for market release
during the second half of 2012 will positively impact revenue this year,
that the number of PCT applications will continue to grow, that the
number of publications and presentations that cite the benefits of PCT
in sample preparation will continue to expand, and that the number of
research scientists introduced to the advantages of PCT will continue to
increase,” said Pressure BioSciences' president and CEO Richard T. Schumacher.
The company also said it believes that its strategy will results in “significantly greater” revenue in 2012 compared to 2011.
In
Guangzhou, China, the company entered into a distribution agreement
with the Yinzhou Police Equipment & Technology Co. for its PCT
product line and for its patent-pending, mechanical homogenization
device, the Shredder SG3, and associated consumables.
Pressure said the deal allows Yinzhou to market and sell the products into the forensics marketplace only.
The
company said it plans to add “one or more” additional distributors in
China for representation outside of the forensics area
during the second half of 2012.
In
Vietnam, Cambodia, and Laos, Pressure entered into a distribution
agreement with BMN MSI Ltd. for its PCT product line and for the
Shredder SG3 homogenization device and associated consumables.
In
Australia and New Zealand, the company entered into a distribution
agreement with iScience Technology for its PCT product line, and for the
Shredder SG3 homogenization device and associated consumables.
All
of the distribution agreements with respect to the PCT products are
exclusive, while deals for distribution of the Shredder SG3
homogenization device and associated consumables are non-exclusive.
Pressure BioSciences
is focused on the development, marketing, and sale of proprietary
laboratory instrumentation and associated consumables based on its PCT
platform.
Earlier this month, the company announced an agreement
with 17 investors for an initial $600,000 tranche of an "above-market"
$1.2 million private placement financing.
Proceeds from the financing will be used toward the commercialization of PCT product platform.
Under
the agreement announced Tuesday, the initial tranche will consist of
the sale of roughly 120,000 units at a price of $5.00 each. The company
said roughly $485,000 of the $600,000 initial tranche was received in
cash, and $115,000 will be from the conversion of debt.
The
seventeen investors in the initial tranche consist of members of the
company’s new and old board of directors, all officers of the company,
and several existing accredited investors in Pressure BioSciences, it said.
The
$600,000 financing was expected to close by July 6, while one or more
additional tranches in the private placement is anticipated to close
before the end of August.
Since Pressure began commercial
operations in the middle of 2007, it has come a long way, releasing a
number of PCT-based products geared towards the $6 billion sample
preparation market, including three pressure-generating instruments
named Barocyclers, a patent-pending sample homogenization device (The
Shredder SG3), five types of single-use processing containers and six
different, application-specific reagent kits.
In early May, the
company announced it signed a strategic co-development, co-marketing,
and co-selling agreement with LEAP Technologies.
Under the
agreement, the companies intend to develop a next generation sample
preparation system by combining Pressure’s PCT platform with LEAP’s
proprietary robotics and lab automation equipment.
LEAP
Technologies has been providing proprietary robotics and laboratory
automation equipment and support for specific applications for over 20
years.
No comments:
Post a Comment